Real-World US Treatment Patterns and Clinical Outcomes in Advanced NSCLC After Prior Platinum Chemotherapy and Immunotherapy

被引：0
|
作者：
Smith, T. [1 ]
Knoll, S. [1 ]
Martinalbo, J. [2 ]
Ye, F. [1 ]
Kolaei, F. [2 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
[2] Novartis Oncol, Basel, Switzerland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
Advanced NSCLC; post-ICI and PDC; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10.07
引用
收藏
页码：S1001 / S1001
页数：1
相关论文
共 50 条
  • [41] Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan
    Kita, Yuki
    Otsuka, Hikari
    Ito, Katsuhiro
    Hara, Takuto
    Shimura, Soichiro
    Kawahara, Takashi
    Kato, Minoru
    Kanamaru, Sojun
    Inoue, Koji
    Ito, Hiroki
    Igarashi, Atsushi
    Sazuka, Tomokazu
    Takamatsu, Dai
    Hashimoto, Kohei
    Abe, Takashige
    Naito, Sei
    Matsui, Yoshiyuki
    Nishiyama, Hiroyuki
    Kitamura, Hiroshi
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (05) : 552 - 559
  • [42] Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan
    Abu Hejleh, Taher
    Alsawalha, Karim
    Abdel Hafiz, Sufian
    Al-Batsh, Tamer
    Abu Hejleh, Roaa
    Yaser, Sameer
    Abu Jazar, Husam
    Khader, Jamal
    Alnsour, Anoud
    Mohamad, Issa
    Abdel Jalil, Riad
    Abu-Shanab, Ahmad
    Gharaibeh, Azza
    Abu Shattal, Mohammad
    Alibraheem, Akram
    Haddad, Hussam
    Mahmoud, Naser
    Obeidat, Shadi
    Al-Jaghbeer, Mohammed J.
    Furqan, Muhammad
    Cortellini, Alessio
    Velcheti, Vamsidhar
    Al-rabi, Kamal
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [43] Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small Cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan
    Leal, Ticiana A.
    Dasgupta, Anandaroop
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Rai, Pragya
    Barlesi, Fabrice
    Liu, Stephen V.
    JCO GLOBAL ONCOLOGY, 2024, 10
  • [44] Platinum-based chemotherapy combined with endostar in the treatment of advanced NSCLC: A real world study.
    Jiang, Wei
    Sun, Wei
    Li, Wenhui
    Gao, Jing
    Wang, Hui
    Zhou, Wei
    Liang, Jing
    Aa, Lixiang
    Zhao, Changhong
    Wang, Luhua
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Real-world clinical outcomes after progression with anti-PD(L)1 and chemotherapy in mNSCLC in the US
    Liu, Stephen V.
    Dasgupta, Anandaroop
    Latremouille-Viau, Dominick
    Rossi, Carmine
    Rai, Pragya
    Barlesi, Fabrice
    Leal, Ticiana A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E12 - E12
  • [46] Real-World Data: Survival Outcomes of Chemotherapy Regimens Given Concurrently with Radiotherapy for Locally Advanced NSCLC
    Tsui, D. C. C.
    Butts, C.
    Ghosh, S.
    Sangha, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S863 - S863
  • [47] Real-world treatment patterns for advanced EGFR wild-type NSCLC in second or third line in a large US database
    Li, Y.
    Pattipaka, T.
    Chia, Y.
    Walls, R.
    Hooper, G.
    Taylor, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [48] Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients
    Taugner, J.
    Kaesmann, L.
    Eze, C.
    Floersch, B.
    Guggenberger, J.
    Tufman, A.
    Reinmuth, N.
    Duell, T.
    Belka, C.
    Manapov, F.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S968 - S968
  • [49] Real-world impact of the platinum chemotherapy shortage on advanced cancer patients
    Reibel, J. B.
    Hubbard, R.
    Sun, L.
    Parikh, R. B.
    Martin, L. P.
    Mamtani, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S942 - S943
  • [50] Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
    Taugner, Julian
    Kaesmann, Lukas
    Eze, Chukwuka
    Ruehle, Alexander
    Tufman, Amanda
    Reinmuth, Niels
    Duell, Thomas
    Belka, Claus
    Manapov, Farkhad
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (04) : 1189 - 1196
12345